Take this simple quiz to determine if you’re a good candidate for TMS treatment. TMS is a safe and effective non-medication treatment for depression. It’s FDA cleared, covered by most insurance plans and has minimal side effects.

The Patient Health Questionnaire (PHQ-9) is a self-assessment tool for depression. It has nine parts: one for each of the diagnostic criteria for depression, according to the DSM-IV. PHQ-9 results are scored based on the frequency of depressive symptoms, from 0 (“not at all”) to 3 (“nearly every day”). Clinically, the PHQ-9 is used to monitor the severity of a patient’s depression and/or a patient’s response to treatment.

The PHQ-9 is an important tool for tracking the progress of depression symptoms during and after TMS, a highly effective and non-invasive treatment for major depressive disorder.

About Active Path Mental Health

Transcranial magnetic stimulation (TMS) was approved by the Food and Drug Administration in 2008 as an electromagnetic treatment for depression. Particularly useful in cases of severe depression that have not responded to antidepressant drugs, TMS boasts “significant remission (32.6%) and response (38.4%) rates.” Active Path Mental Health has been treating patients in the Portland area since January 2017.

Identifying the symptoms and understanding the severity of depression has never been more important. For the past four decades, doctors have used the PHQ-9 depression screening tool, a carefully constructed questionnaire, to better understand each patient’s individual condition. But what is PHQ-9 an acronym for? And how does it help treat depression? The PHQ-9 falls under the broader testing tool known as the “Patient Health Questionnaire,” (PHQ). Among various indicators of depression, the PHQ-9 asks patients to rate their symptoms on a scale from 0-3, “not at all” to “nearly every day.” The tallied score indicates the severity of the patient’s depression.

In studies both in the United States and worldwide, transcranial magnetic stimulation (TMS) is an effective treatment for depression, per the PHQ-9 scale.

When Pam took the Patient Health Questionnaire (PHQ-9), her baseline was categorized at 19, or “moderately severe”, thanks to the cascading effects of her ADHD, brain fog, and treatment-resistant depression.

And after finishing treatment?

“My score has not been above 2 since finishing TMS.”